The Recall Desk

Manufacturer

Jubilant Cadista Pharmaceuticals, Inc.

31 recalls in our database name Jubilant Cadista Pharmaceuticals, Inc. as the manufacturing or recalling firm.

What the numbers show

Total
31
Critical
0
Severe
4
Most recent
2023-01-11

Of the 31 recalls from Jubilant Cadista Pharmaceuticals, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 4 (13%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–25 of 31

  • ModerateFDA (Drugs)·D-0096-2023·2023-01-11

    Prochlorperazine Maleate tablets recalled for subpotency: out of specification at stability testing

    Jubilant Cadista Pharmaceuticals recalls 14,061 bottles of Prochlorperazine Maleate 5mg tablets nationwide due to subpotency. The medication failed quality testing at 18 months and contains less active ingredient than specified.

    Product
    PROCHLORPERAZINE MALEATE — PROCHLORPERAZINE MALEATE (PROCHLORPERAZINE MALEATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1293-2022·2022-08-03

    Irbesartan Blood Pressure Tablets Recalled Due to Failed Dissolution

    Jubilant Cadista is recalling 9,600 bottles of Irbesartan Tablets (150mg) nationwide due to failed dissolution specifications. Affected lot IB220023A expires 08/2022.

    Product
    IRBESARTAN — IRBESARTAN (IRBESARTAN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-1294-2022·2022-08-03

    Jubilant Cadista Irbesartan tablets recalled due to failed dissolution

    Jubilant Cadista Pharmaceuticals is recalling 28,560 bottles of Irbesartan 75 mg tablets nationwide due to failed dissolution specifications that may compromise drug efficacy.

    Product
    IRBESARTAN — IRBESARTAN (IRBESARTAN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0752-2022·2022-04-13

    FDA Voluntary Recall of Methylprednisolone Tablets for Subpotency

    Jubilant Cadista Pharmaceuticals is recalling Methylprednisolone Tablets USP 4mg because they contain less active ingredient than labeled. Lot 21 P0322 was distributed nationwide and in Puerto Rico.

    Product
    Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0767-2022·2022-04-06

    Meclizine Hydrochloride Tablets Recalled Due to Incorrect Label Mix-up

    Jubilant Cadista Pharmaceuticals recalls Meclizine Hydrochloride Tablets with incorrect labeling. Bottles labeled as PredniSONE contain Meclizine, risking medication errors.

    Product
    MECLIZINE HYDROCHLORIDE — MECLIZINE HYDROCHLORIDE (MECLIZINE HYDROCLORIDE)
    Category
    Drug
    Distribution
    5 states
  • LowFDA (Drugs)·D-0784-2021·2021-09-08

    Donepezil HCL Tablets 5 mg Recalled for Subpotency

    Jubilant Cadista Pharmaceuticals is recalling Donepezil HCL Tablets, USP, 5 mg (Lot # DN120006A, exp. 12/2021) because the tablets are subpotent—meaning they contain less active ingredient than specified. The recall affects 14,544 bottles distributed nationwide.

    Product
    Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0333-2021·2021-04-21

    Jubilant Cadista Recalls Itraconazole Capsules Due to Dissolution Failures

    Jubilant Cadista Pharmaceuticals is recalling specific lots of Itraconazole Capsules, 100 mg, because they failed to meet dissolution specifications.

    Product
    Itraconazole Capsules, 100 mg, 30-count bottles, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-282-30.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0298-2021·2021-03-10

    Jubilant Cadista Recalls Methylprednisolone Tablets Due to Illegible Labeling

    Jubilant Cadista Pharmaceuticals is recalling specific lots of Methylprednisolone Tablets USP, 4 MG, due to misaligned printing on the blister card that makes dosing instructions illegible.

    Product
    Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0104-2021·2020-12-02

    Jubilant Cadista Recalls Clomipramine Hydrochloride Capsules Due to Specification Failure

    Jubilant Cadista Pharmaceuticals is recalling 4,416 bottles of clomipramine hydrochloride capsules because they failed tablet/capsule specifications.

    Product
    clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0066-2021·2020-11-11

    Jubilant Recalls Subpotent Olanzapine Orally Disintegrating Tablets Nationwide

    Jubilant Cadista Pharmaceuticals is voluntarily recalling 23,616 blister packs of Olanzapine Orally Disintegrating Tablets, 5 mg, because the product was found to be subpotent.

    Product
    Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1281-2020·2020-06-03

    Lamotrigine Tablets Recalled for Presence of Foreign Silica Granules

    Jubilant Cadista Pharmaceuticals is recalling Lamotrigine Tablets, 150 mg, due to the presence of foreign silica granules consistent with desiccant pack material.

    Product
    Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-1058-2020·2020-03-25

    Jubilant Cadista Recalls Pantoprazole Sodium Tablets Due to CGMP Deviations

    Jubilant Cadista Pharmaceuticals is recalling 89,376 bottles of Pantoprazole Sodium Delayed-Release Tablets due to dark brown discoloration on tablet edges.

    Product
    Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by Jubilant Generics Ltd, Roorkee-247661 India, NDC 59746-284-90
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0576-2020·2019-12-18

    Jubilant Cadista Recalls Amantadine Hydrochloride Tablets Due to Foreign Object

    Jubilant Cadista Pharmaceuticals is recalling 1,824 bottles of Amantadine Hydrochloride Tablets because a foreign object was found in a single tablet.

    Product
    Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0145-2020·2019-10-23

    Jubilant Cadista Recalls Pantoprazole Sodium Tablets Due to Discoloration

    Jubilant Cadista Pharmaceuticals is recalling specific lots of Pantoprazole Sodium Delayed Release Tablets due to dark brown discoloration on tablet edges.

    Product
    Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90
    Category
    Drug
    Distribution
    5 states
  • SevereFDA (Drugs)·D-1837-2019·2019-08-07

    Jubilant Cadista Recalls Drospirenone and Ethinyl Estradiol Tablets for Dissolution Failure

    Jubilant Cadista Pharmaceuticals is recalling specific lots of Drospirenone and Ethinyl Estradiol Tablets because they failed dissolution specifications during stability testing.

    Product
    Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each blister card contains 28-film coated, biconvex tablets, Rx Only, Manufactured by: Cyndea Pharma, S.L., Olvega (Soria), 42110 Spain, Distributed by: Jubilant Cadis
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1074-2019·2019-04-10

    Jubilant Cadista Recalls Pantoprazole Sodium Tablets Due to Discoloration

    Jubilant Cadista Pharmaceuticals is recalling 12,960 bottles of Pantoprazole Sodium Delayed-Release Tablets due to dark brown discoloration on the tablet edges.

    Product
    Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0519-2019·2019-03-13

    Jubilant Cadista Recalls Bupropion Hydrochloride Extended-Release Tablets for Dissolution Failure

    Jubilant Cadista Pharmaceuticals is recalling specific lots of Bupropion Hydrochloride Extended-Release Tablets because they failed dissolution specifications at a 9-month stability timepoint.

    Product
    BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) & b) 90 count (NDC 59746-758-90) bottles, Rx only, Manufactured b Jubilant Generis Ltd, Roorkee, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-0011-2019·2018-10-17

    Jubilant Cadista Recalls Pantoprazole Tablets Due to Dark Discoloration

    Jubilant Cadista Pharmaceuticals is recalling 158,466 bottles of 40 mg pantoprazole sodium delayed-release tablets due to dark discoloration or brown spots on the edges.

    Product
    Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1205-2018·2018-09-26

    Jubilant Cadista Recalls Methylprednisolone Tablets for Stability Failure

    Jubilant Cadista Pharmaceuticals is recalling Methylprednisolone Tablets due to failed stability testing. The product was distributed throughout the United States.

    Product
    MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD NDC 59746-001-03
    Category
    Drug
    Distribution
    0 states